Unicycive Therapeutics Inc [NASDAQ: UNCY] gained 0.38% or 0.0 points to close at $0.60 with a heavy trading volume of 184028 shares.
The daily chart for UNCY points out that the company has recorded 50.08% gains over the past six months.
If we look at the average trading volume of 983.26K shares, UNCY reached to a volume of 184028 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Unicycive Therapeutics Inc [UNCY]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for UNCY shares is $6.79 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on UNCY stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for Unicycive Therapeutics Inc shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 04, 2024.
The Average True Range (ATR) for Unicycive Therapeutics Inc is set at 0.06 The Price to Book ratio for the last quarter was 9.20, with the Price to Cash per share for the same quarter was set at 0.22.
Trading performance analysis for UNCY stock
Unicycive Therapeutics Inc [UNCY] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 13.24. With this latest performance, UNCY shares dropped by -9.58% in over the last four-week period, additionally plugging by 50.08% over the last 6 months – not to mention a drop of -46.40% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for UNCY stock in for the last two-week period is set at 54.21, with the RSI for the last a single of trading hit 57.83, and the three-weeks RSI is set at 52.38 for Unicycive Therapeutics Inc [UNCY]. The present Moving Average for the last 50 days of trading for this stock 0.5754, while it was recorded at 0.5899 for the last single week of trading, and 0.5214 for the last 200 days.
Unicycive Therapeutics Inc [UNCY]: A deeper dive into fundamental analysis
Unicycive Therapeutics Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.28 and a Current Ratio set at 1.28.
An analysis of Institutional ownership at Unicycive Therapeutics Inc [UNCY]
There are presently around $52.37%, or 55.30%% of UNCY stock, in the hands of institutional investors. The top three institutional holders of UNCY stocks are: VIVO CAPITAL, LLC with ownership of 3.47 million shares, which is approximately 9.9395%. LOGOS GLOBAL MANAGEMENT LP, holding 3.47 million shares of the stock with an approximate value of $$1.74 million in UNCY stocks shares; and LOGOS GLOBAL MANAGEMENT LP, currently with $$1.41 million in UNCY stock with ownership which is approximately 8.0783%.
